Andere talen Ajanta Pharma Limited Bombay S.E.

Aandelen

AJANTPHARM

INE031B01049

Beurs gesloten - Bombay S.E. Andere beurzen 12:00:47 15-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2.395 ^INR	-1,76%		-0,16%	+14,89%

03/05	INDIA STOCKS-India's Nifty 50 zakt van recordhoogte door IT-aandelen die wegen	RE
02/05	Geconsolideerde winst Ajanta Pharma verdubbelt bijna in fiscaal vierde kwartaal	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh	03/05
Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4	02/05
Ajanta Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	02/05
Ajanta Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	02/05
Ajanta Pharma Limited announces an Equity Buyback for 1,028,881 shares, representing 0.82% for INR 2,850 million.	02/05
Ajanta Pharma Limited authorizes a Buyback Plan.	02/05
Ajanta Pharma Limited?s Board intends to launch an Equity Buyback on May 2, 2024.	26/04
Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit	02/02
Ajanta Pharma Limited Approves Second Interim Dividend for the Year Fiscal Year 2024, Payable on or After 19th February 2024	31/01
Ajanta Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	31/01
Ajanta Pharma Board to Consider Second Interim Dividend for Fiscal 2024	25/01
Ajanta Pharma Limited Provides Earnings Guidance for the Full Year of Fiscal 2024	31-10-23
Ajanta Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	31-10-23
Ajanta Pharma Gets US FDA Nod for Topiramate Extended-Release Capsules	31-08-23
Ajanta Pharma Limited Receives Final Approval from US FDA for Topiram Extended Release Capsules	30-08-23
Ajanta Pharma Logs Increase in Fiscal Q1 Consolidated Profit	28-07-23
Ajanta Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	27-07-23
Ajanta Pharma Board to Consider Interim Dividend for Fiscal 2024	24-07-23
Ajanta Pharma Limited Confirms the Interim Dividend for the Year Ended 31 March 2023	18-07-23
Ajanta Pharma Gets No Observations After US FDA's Inspection of API Facility in Hyderabad, India	26-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ajanta Pharma Limited Bombay S.E.

Aandelen

AJANTPHARM

INE031B01049

Andere talen

Filters